المؤلفون: Kempf, M., Varon, E., Lepoutre, A., Gravet, A., Baraduc, R., Brun, M., Chardon, H., Cremniter, J., Croizé, J., Dalmay, F., Demachy, M.-C., Fosse, T., Grelaud, C., Hadou, T., Hamdad, F., Koeck, J.-L., Luce, S., Mermond, S., Patry, I., Péchinot, A., Raymond, J., Ros, A., Segonds, C., Soullié, B., Tandé, D., Vergnaud, M., Vernet-Garnier, V., Wallet, F., Gutmann, L., Ploy, M.-C., Lanotte, P.

المصدر: Clinical Microbiology and Infection ; volume 21, issue 1, page 35-42 ; ISSN 1198-743X

مصطلحات موضوعية: Infectious Diseases, Microbiology (medical), General Medicine

الإتاحة: https://doi.org/10.1016/j.cmi.2014.08.009Test
https://api.elsevier.com/content/article/PII:S1198743X14000160?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1198743X14000160?httpAccept=text/plainTest

المؤلفون: Mader, R., Demay, C., Jouvin-Marche, E., Ploy, M. -C., Barraud, O., Bernard, S., Lacotte, Y., Pulcini, C., Weinbach, J., Berling, C., Bouqueau, M., Hlava, A., Habl, C., Kernstock, E., Strauss, R., Muchl, R., Buhmann, V., Versporten, A., Ingenbleek, A., Vandael, E., Haelterman, G., De Raedt, L., Hunjak, B., Raickovic, B., Mackova, B., Niklova, E., Zemlickova, H., Hrivnakova, L., Jindrak, V., Kristensen, B., Lyndrup, M., Skovgaard, S., Wolf Sonksen, U., Aasmae, B., Ruut, J., Linnik, L., Sadikova, O., Martin, P., Zanuzdana, A., Kizilkaya-Guneser, G., Oezcelik, N., Eckmanns, T., Lambrou, A., Kontopidou, F., Papadaki, M., Tsana, M., Maroulis, N., Vatopoulos, A., Papadogiannakis, E., Kontarini, M., Gikas, A., Magkanaraki, A., Cozza, A., Martinelli, D., Fortunato, F., Prato, R., Marella, A. M., Pantosti, A., Prestinaci, F., Busani, L., Pezzoti, P., Creti, R., Martoccia, R. M., Brusaferro, S., Vilde, A., Jakovela, A., Langusa, E., Grudule, L., Grinsteine, M., Dumpis, U., Dambrauskiene, A., Vitkauskiene, A., Tirvaite, D., Cemnalianskis, L., Kazenaite, E., Lozoraitiene, I., Adomaitiene, R., Ambrazaitiene, R., Kiveryte, S., Maciulaityte, A., Kuklyte, J., Petrene, J., Valinteliene, R., Kanapeckiene, V., Razmiene, A., Kairiene, B., Aleksiene, G., Valinciute, G., Petraitis, R., Elsemulder, A., Nakched, A., Claessen, J., Gui, L., Kort, M. D., Peran, R., Van Leeuwen, A., Smeets, E., Mennen, M., Spruijt, P., Westerhof, R., Skulberg, A., Bakka, E. Ro., Miard, K., Henricsen, S. Ho., Pellerud, A., Kallberg, C., Ardal, C., Eriksen, H. -M., Kranstad, K., Molvik, M., Kacelnik, O., Sollund, P., Samuelsen, R., Bakke, T., Urdahl, A. M., Norstrom, M., Olczak-Pienkowska, A., Skoczynska, A., Zabicka, D., Bysiek, J., Rekawek, J., Lebre, A., Falcao, E., Scripcaru, G., Neves, I., Gomes, S., Pereira, N., Malutan, A. M., Iuhas, C., Szakacs, L., Kissiedou-Bob, M., Ciortea, R., Grilc, E., Klavs, I., Turk, K., Subelj, M., Vrdelja, M., Serdt, M., Jemec, N., Glavan, U., Simonovic, Z., Tamayo, A. N., Lopez Navas, A., Munoz Madero, C., Alonso Lebrero, J. L., Alonso Irujo, L., Santacreu Garcia, M., Crespo Robledo, P., Oliva, G., Massanes, M., Oliver Palomo, A., Garcia Pineda, A., Ferragut, E., Rojo, E., Castano, E., Perianez, L., Torres Cantero, A. M., Jimenez Guillen, C., Hukelova, H., Alcaraz, M., Carlos, M. A., Lopez Acuna, M. D. P., Gil Setas, A., Ibarrola Segura, A., Ezpeleta, C., Gahigiro Merino, C., Portillo Bordonabe, M. E., Fragoso, M., Beristain Rementeria, X., Penalva, G., Cisneros, J. M., Estevez, M., Monteau, S., Del Rio, L., Gonzalez De Suso, M. J., Gallego Berciano, P., Aranguren Oyarzabal, A., Alioto, D., Izquierdo Palomares, J. M., Calvo Alcantara, M. J., Gonzalez Perez, R., Havarria, T., Hulth, A., Carlin, K., Edman, L., Grape, M., Aspevall, O., Haggar, A., Lindal, E., Burgos, A., Ottoson, J., Ostman, M., Egervarn, M., Nordenfelt, A., Bengtsson, B., Soderman, I., Bjers, A., Jonsson, J. -I., Starborg, M., Laine, M., Fagerstedt, P., Metcalfe, A., Soder, J., Lytsy, B., Madec, J. Y., Collineau, L., Berger-Carbonne, A., Colomb-Cotinat, M., Bourely, C., Amat, J. -P., Broens, E. M., Callens, B., Crespo-Robledo, P., Damborg, P., Filippitzi, M. -E., Fitzgerald, W., Gronthal, T., Haenni, M., Heuvelink, A., Van Hout, J., Kaspar, H., Pedersen, K., Pokludova, L., Dal Pozzo, F., Slowey, R., Zafeiridis, C., Madec, J. -Y.

المساهمون: Departments of Faculty of Veterinary Medicine

المصدر: Journal of Antimicrobial Chemotherapy, 77(3), 816. Oxford University Press
EU-JAMRAI 2022, ' Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet) : a bottom-up and One Health approach ', The Journal of antimicrobial chemotherapy, vol. 77, no. 3, pp. 816-826 . https://doi.org/10.1093/jac/dkab462Test
Journal of antimicrobial chemotherapy, Oxford : Oxford University Press, 2022, vol. 77, iss. 3, p. 816-826
bioRxiv

مصطلحات موضوعية: Microbiology (medical), Veterinary medicine, Staphylococcus pseudintermedius, 040301 veterinary sciences, Swine, Drug Resistance, 413 Veterinary science, 0403 veterinary science, Animals, Anti-Bacterial Agents, Bacteria, Cats, Cattle, Chickens, Dogs, Drug Resistance, Bacterial, Female, One Health, 03 medical and health sciences, Antibiotic resistance, Antimicrobial stewardship, Medicine, Pharmacology (medical), 2. Zero hunger, Streptococcus uberis, Pharmacology, 0303 health sciences, biology, 030306 microbiology, business.industry, Bacterial, 04 agricultural and veterinary sciences, biology.organism_classification, Antimicrobial, Food safety, 3. Good health, Infectious Diseases, business, Streptococcus dysgalactiae

الوصف: BackgroundBuilding the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet) was proposed to strengthen the European One Health antimicrobial resistance (AMR) surveillance approach.ObjectivesThe objectives were to (i) define the combinations of animal species, production types, age categories, bacterial species, specimens and antimicrobials to be monitored in EARS-Vet and to (ii) determine antimicrobial test panels able to cover most combinations.MethodsThe EARS-Vet scope was defined by consensus between 26 European experts. Decisions were guided by a survey of the combinations that are relevant and feasible to monitor in diseased animals in 13 European countries (bottom-up approach). Experts also considered the One Health approach and the need for EARS-Vet to complement existing European AMR monitoring systems coordinated by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).ResultsEARS-Vet would monitor AMR in six animal species (cattle, swine, chicken (broiler and laying hen), turkey, cat and dog), for 11 bacterial species (Escherichia coli, Klebsiella pneumoniae, Mannheimia haemolytica, Pasteurella multocida, Actinobacillus pleuropneumoniae, Staphylococcus aureus, Staphylococcus pseudintermedius, Staphylococcus hyicus, Streptococcus uberis, Streptococcus dysgalactiae and Streptococcus suis). Relevant antimicrobials for their treatment were selected (e.g. tetracyclines) and complemented with antimicrobials of more specific public health interest (e.g. carbapenems). Three test panels of antimicrobials were proposed covering most EARS-Vet combinations of relevance for veterinary antimicrobial stewardship.ConclusionsWith this scope, EARS-Vet would enable to better address animal health in the strategy to mitigate AMR and better understand the multi-sectoral AMR epidemiology in Europe.

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c03cd9abbc31dd8e611ee23aebf903Test
https://hdl.handle.net/1874/419152Test

المؤلفون: Hays, C., Lienhard, R., Auzou, M., Barraud, O., Guerin, F., Ploy, M.-C., Cattoir, V.

المصدر: Journal of Antimicrobial Chemotherapy ; volume 69, issue 8, page 2056-2060 ; ISSN 0305-7453 1460-2091

مصطلحات موضوعية: Infectious Diseases, Pharmacology (medical), Pharmacology, Microbiology (medical)

الإتاحة: https://doi.org/10.1093/jac/dku099Test

المؤلفون: Larsson, D. G. Joakim, 1969, Andremont, Antoine, Bengtsson-Palme, Johan, 1985, Brandt, K. K., Husman, A. M. D., Fagerstedt, P., Fick, J., Flach, Carl-Fredrik, 1977, Gaze, W. H., Kuroda, M., Kvint, Kristian, 1964, Laxminarayan, R., Manaia, C. M., Nielsen, K. M., Plant, L., Ploy, M. C., Segovia, C., Simonet, P., Smalla, K., Snape, J., Topp, E., van Hengel, A. J., Verner-Jeffreys, D. W., Virta, M. P. J., Wellington, E. M., Wernersson, A. S.

المصدر: Environment International. 117:132-138

مصطلحات موضوعية: Infectious Medicine, Infektionsmedicin, Antimicrobial resistance, Infectious diseases, Risk assessment, Risk management, Environmental, horizontal gene-transfer, antimicrobial resistance, risk-assessment, escherichia-coli, waste-water, policy interventions, protection goals, bacteria, pathogens, evolution, Environmental Sciences & Ecology, . European Commission, IENCESRoyal Society Discussion Meeting on Antimicrobial Resistance Addressing the Threat to Global, ENIHR. Scientific committee on emerging and newly identified health risks (SCENIHR)

الوصف: There is growing understanding that the environment plays an important role both in the transmission of antibiotic resistant pathogens and in their evolution. Accordingly, researchers and stakeholders world-wide seek to further explore the mechanisms and drivers involved, quantify risks and identify suitable interventions. There is a clear value in establishing research needs and coordinating efforts within and across nations in order to best tackle this global challenge. At an international workshop in late September 2017, scientists from 14 countries with expertise on the environmental dimensions of antibiotic resistance gathered to define critical knowledge gaps. Four key areas were identified where research is urgently needed: 1) the relative contributions of different sources of antibiotics and antibiotic resistant bacteria into the environment; 2) the role of the environment, and particularly anthropogenic inputs, in the evolution of resistance; 3) the overall human and animal health impacts caused by exposure to environmental resistant bacteria; and 4) the efficacy and feasibility of different technological, social, economic and behavioral interventions to mitigate environmental antibiotic resistance.(1)

الوصول الحر: https://gup.ub.gu.se/publication/269197Test

المؤلفون: Desroches, Marine, Potier, Julien, Laurent, Frédéric, Bourrel, Anne-Sophie, Doucet-Populaire, Florence, Decousser, Jean-Winoc, on behalf of the Microbs Study Group, Archambaud, M., Aubert, G., Biendo, M., Blanchard-Marche, G., Bonnet, R., Robin, F., Bourgeois-Nicolaos, N., Bret, L., Caillon, J., Caron, F., Cattoen, C., Chachaty, E., Courtade, H., Eloy, C., Etienne, J., Vandenesch, F., Fiacre, A., Girard-Pipau, F., Buisson-Touati, C., Jean-Pierre, H., Jehl, F., Leclercq, R., Cattoir, V., Lavigne, J. P., Lina, G., Loiez-Durocher, C., Lozniewski, A., Aissa, N., Maurin, M., Morand, P., Nicolas-Chanoine, M. H., Nordmann, P., Fortineau, N., Patry, I., Plouzeau-Jayle, C., Ploy, M. C., Rostane, H., Roussel-Gaillard, T., Rio, Y., Tankovic, J., Texier-Maugein, J., Vernet-Garnier, V.

مصطلحات موضوعية: Original research

الوصف: Objectives Mupirocin is the cornerstone of decolonization regimens, a successful strategy to prevent healthcare-associated staphylococcal infections. Several recent studies have reported alarming results: (i) an extending reservoir of mupA , the ancestral mobile resistance gene, among coagulase-negative staphylococci (CoNS); (ii) the emergence of a new resistance gene ( mupB ); and (iii) a growing number of mupirocin-resistant methicillin-resistant Staphylococcus aureus (MRSA), including highly pathogenic clones. We performed a nationwide prospective study in France to detect such trends among invasive staphylococci. Methods Between October 2011 and February 2012, 367 MRSA and 708 CoNS invasive isolates were collected from 37 hospitals and analysed centrally. Mupirocin MICs were determined using the broth microdilution method. mupA/B PCR was performed for resistant isolates (MIC >1 mg/L). Genetic relatedness between mupirocin-resistant MRSA isolates was determined by PFGE analysis and related isolates were tested by microarray. Results Among MRSA isolates 2.2% ( n = 8) were classified as mupirocin resistant; 1.4% ( n = 5) showing low-level resistance (MIC ≤256 mg/L) and 0.8% ( n = 3) high-level resistance (MIC >256 mg/L). Only the latter isolates carried mupA . A clonal relationship was identified between two mupA -negative MRSA from the same hospital and three mupA -positive MRSA from three distant towns; these three isolates belonged to the Lyon clone. Mupirocin resistance was identified in 10.3% of CoNS, mainly highly resistant mupA -positive isolates (5.6%). The mupB gene was not detected in mupirocin-resistant MRSA or CoNS. Conclusions This first large national study indicates the need for thorough epidemiological monitoring and a stewardship programme to prevent and detect mupirocin resistance in staphylococci.

وصف الملف: text/html

العلاقة: http://jac.oxfordjournals.org/cgi/content/short/dkt085v1Test; http://dx.doi.org/10.1093/jac/dkt085Test

الإتاحة: https://doi.org/10.1093/jac/dkt085Test
http://jac.oxfordjournals.org/cgi/content/short/dkt085v1Test

المؤلفون: Barraud, O., Casellas, M., Dagot, C., Ploy, M.-C.

المصدر: Clinical Microbiology and Infection ; volume 19, issue 7, page E306-E308 ; ISSN 1198-743X

مصطلحات موضوعية: Infectious Diseases, Microbiology (medical), General Medicine

الإتاحة: https://doi.org/10.1111/1469-0691.12186Test
https://api.elsevier.com/content/article/PII:S1198743X14618528?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1198743X14618528?httpAccept=text/plainTest

المؤلفون: Hidri, N., Barraud, O., de Martino, S., Garnier, F., Paraf, F., Martin, C., Sekkal, S., Laskar, M., Jaulhac, B., Ploy, M.-C.

المصدر: Clinical Microbiology and Infection ; volume 18, issue 12, page E531-E532 ; ISSN 1198-743X

مصطلحات موضوعية: Infectious Diseases, Microbiology (medical), General Medicine

الإتاحة: https://doi.org/10.1111/1469-0691.12016Test
https://api.elsevier.com/content/article/PII:S1198743X14608156?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1198743X14608156?httpAccept=text/plainTest

المؤلفون: Guerin, E., Jove, T., Tabesse, A., Mazel, D., Ploy, M.-C.

المصدر: Journal of Bacteriology ; volume 193, issue 20, page 5675-5682 ; ISSN 0021-9193

الإتاحة: https://doi.org/10.1128/jb.05246-11Test

المؤلفون: Barraud, O., Baclet, M. C., Denis, F., Ploy, M. C.

مصطلحات موضوعية: Original research

الوصف: Objectives Integrons are bacterial genetic elements that can capture and express genes contained in mobile cassettes. Integrons have been described worldwide in Gram-negative bacteria and are a marker of antibiotic resistance. We developed a specific and sensitive Taqman® probe-based real-time PCR method with three different primer–probe pairs for simultaneous detection of the three main classes of integron. Methods Sensitivity was assessed by testing mixtures of the three targets ( intI integrase genes of each integron class) ranging from 10 to 108 copies. Specificity was determined with a panel of integron-containing and integron-free control strains. The method was then applied to clinical samples. Results The PCR method was specific and had a sensitivity of 102 copies for all three genes, regardless of their respective quantities. The method was quantitative from 103 to 107 copies, and was able to detect integrons directly in biological samples. Conclusions We have developed a rapid, quantitative, specific and sensitive method that could prove useful for initial screening of Gram-negative isolates, or clinical samples, for likely multidrug resistance.

وصف الملف: text/html

العلاقة: http://jac.oxfordjournals.org/cgi/content/short/dkq167v1Test; http://dx.doi.org/10.1093/jac/dkq167Test

الإتاحة: https://doi.org/10.1093/jac/dkq167Test
http://jac.oxfordjournals.org/cgi/content/short/dkq167v1Test

المؤلفون: Gassama Sow, A., Diallo, M. H., Gatet, M., Denis, F., Aidara-Kane, A., Ploy, M.-C.

المصدر: Journal of Antimicrobial Chemotherapy ; volume 62, issue 4, page 843-844 ; ISSN 0305-7453 1460-2091

مصطلحات موضوعية: Infectious Diseases, Pharmacology (medical), Pharmacology, Microbiology (medical)

الإتاحة: https://doi.org/10.1093/jac/dkn264Test
http://academic.oup.com/jac/article-pdf/62/4/843/2179223/dkn264.pdfTest